Other
no aspirin
no aspirin is an intervention with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
4
80%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
4(80.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Withdrawn1
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 44 (80.0%)
Trials by Status
completed120%
unknown120%
withdrawn120%
active_not_recruiting120%
recruiting120%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_4
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069
active_not_recruitingphase_4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
NCT04609111
unknownphase_4
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT05125276
completedphase_4
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
NCT00110448
withdrawnphase_3
The Effect Of Aspirin On Survival in Lung Cancer
NCT01058902
Clinical Trials (5)
Showing 5 of 5 trials
NCT05347069Phase 4
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT04609111Phase 4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
NCT05125276Phase 4
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT00110448Phase 4
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
NCT01058902Phase 3
The Effect Of Aspirin On Survival in Lung Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5